HomeCompareAXON vs ROL

AXON vs ROL: Dividend Comparison 2026

AXON yields 0.48% · ROL yields 1.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ROL wins by $14.15M in total portfolio value
10 years
AXON
AXON
● Live price
0.48%
Share price
$415.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$49.72
Full AXON calculator →
ROL
ROL
● Live price
1.38%
Share price
$53.04
Annual div
$0.73
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$14.17M
Annual income
$12,435,164.79
Full ROL calculator →

Portfolio growth — AXON vs ROL

📍 ROL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAXONROL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AXON + ROL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AXON pays
ROL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AXON
Annual income on $10K today (after 15% tax)
$40.96/yr
After 10yr DRIP, annual income (after tax)
$42.26/yr
ROL
Annual income on $10K today (after 15% tax)
$116.99/yr
After 10yr DRIP, annual income (after tax)
$10,569,890.07/yr
At 15% tax rate, ROL beats the other by $10,569,847.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AXON + ROL for your $10,000?

AXON: 50%ROL: 50%
100% ROL50/50100% AXON
Portfolio after 10yr
$7.10M
Annual income
$6,217,607.25/yr
Blended yield
87.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on AXON right now

AXON
Analyst Ratings
15
Buy
4
Hold
Consensus: Buy
Price Target
$750.00
+80.7% upside vs current
Range: $690.00 — $820.00
Altman Z
6.4
Piotroski
5/9
ROL
Analyst Ratings
8
Buy
9
Hold
Consensus: Hold
Price Target
$64.00
+20.7% upside vs current
Range: $52.00 — $72.00
Altman Z
10.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AXON buys
0
ROL buys
0
No recent congressional trades found for AXON or ROL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAXONROL
Forward yield0.48%1.38%
Annual dividend / share$2.00$0.73
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%100%
Portfolio after 10y$20.3K$14.17M
Annual income after 10y$49.72$12,435,164.79
Total dividends collected$490.00$14.01M
Payment frequencyquarterlyquarterly
SectorStockIndustrials
Analyst consensusBuyHold
Analyst price target$750.00$64.00

Year-by-year: AXON vs ROL ($10,000, DRIP)

YearAXON PortfolioAXON Income/yrROL PortfolioROL Income/yrGap
1← crossover$10,748$48.18$10,975$275.26$227.00ROL
2$11,549$48.40$12,308$564.69$759.00ROL
3$12,406$48.61$14,353$1,183.69$1.9KROL
4$13,323$48.80$17,938$2,580.15$4.6KROL
5$14,305$48.98$25,221$6,027.23$10.9KROL
6$15,355$49.14$42,827$15,839.73$27.5KROL
7$16,479$49.30$96,098$50,273.53$79.6KROL
8$17,682$49.45$313,681$210,856.41$296.0KROL
9$18,970$49.59$1,622,132$1,286,493.33$1.60MROL
10$20,347$49.72$14,170,846$12,435,164.79$14.15MROL

AXON vs ROL: Complete Analysis 2026

AXONStock

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness, including streamlined investigative workflows. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

Full AXON Calculator →

ROLIndustrials

Rollins, Inc., through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife. It also provides workplace pest control solutions for customers across various end markets, such as healthcare, foodservice, and logistics. In addition, the company offers traditional and baiting termite protection, as well as ancillary services. It serves clients directly, as well as through franchisee operations. Rollins, Inc. was incorporated in 1948 and is headquartered in Atlanta, Georgia.

Full ROL Calculator →
📬

Get this AXON vs ROL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AXON vs SCHDAXON vs JEPIAXON vs OAXON vs KOAXON vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.